Ximedica Acquires Accel Biotech; Creates An Enhanced Offering For Life Science And Biomedical Instrument Product Development And Manufacturing Solutions
PROVIDENCE, R.I. & LOS GATOS, Calif.--(
PROVIDENCE, R.I. & LOS GATOS, Calif.--(BUSINESS WIRE)--XIMEDICA, a leading full service medical technologies development firm
today announced that it has acquired Accel Biotech. Accel Biotech, based
in Los Gatos, CA, expands Ximedica’s design and development offering
into the In vitro Diagnostics, Life Science Laboratory Instruments and
Disposables. The acquisition also expands Ximedica’s West Coast presence
complementing last year’s addition of Bridge
Design in San Francisco.
“Our ethos has always been
about consistently beating time-to-market expectations and innovation.
Ximedica’s vertically integrated processes and similar customer
satisfaction values are a natural match.”
“The acquisition of Accel Biotech deepens the capability, reach and
scale of Ximedica’s comprehensive development offering into key IVD and
Life Science growth segments within the industry that as a firm focused
solely on medical technology we knew we had to pursue” says Randall S.
Barko, Ximedica’s President and Chief Executive Officer.
“Ximedica brings the regulated systems, procedures, discipline and
expertise to complement and enhance Accel Biotech’s wide range of
complex technologies including optics, various detection methods, motion
control/robotics, fluid management and consumables/cartridges. These
combined strengths will bring high value to our clients, offering a risk
averse and cost effective development approach and a depth of expertise
second to none.”
Says Bruce Richardson, Founder of Accel, “Our ethos has always been
about consistently beating time-to-market expectations and innovation.
Ximedica’s vertically integrated processes and similar customer
satisfaction values are a natural match.”
“This is about two organizations combining complementary resources and
establishing a coast-to-coast offering for the design and development of
Life Science and In Vitro Diagnostics (IVD) product technologies. By
joining forces with Ximedica, we will be able to respond to an
increasing demand from our client base for a more comprehensive
offering.”
Accel Biotech, a Ximedica Company, will continue operating out of its
existing Silicon Valley facility and will now have an East Coast
presence servicing existing customers and drawing on the resources of
Ximedica to expand offerings with existing clients and developing new
relationships with key Fortune 100 Medical Technology clients.
Adds Barko, “About two years ago we became a SV Life Sciences portfolio
company and embarked on the next phase of our global growth strategy.
The acquisition of Bridge Design last year and now Accel Biotech moves
us even further along that path.”
Meet with Accel Biotech, a Ximedica company on Aug 2-4 at the 68th
AACC Annual Scientific Meeting & Clinical Lab Expo.
About Ximedica
Ximedica is a full-service ISO 13485-certified and FDA-registered
product development firm. For 30 years Ximedica has
provided a unique growth platform enabling organizations to successfully
deploy medical technology products into the market. Its headquarters are
in Providence, R.I., with offices in Hong Kong, Minneapolis, San
Francisco and Los Gatos. In November of 2014, SV Life Sciences, a
Boston-based private equity firm, acquired a majority stake in Ximedica,
enabling the company to execute its growth strategy. www.ximedica.com
About Accel Biotech
Our mission at Accel Biotech, based in Los Gatos, CA, is to pair
our unique breadth of engineering and design experience in diagnostics,
life sciences and disposables with a passion for quick development. We
enable rapid prototyping with in-house machining, 3D printing and full
production runs for complex devices. We value customer satisfaction
above all else, seeking long-lasting relationships with our clients.
www.accelbiotech.com